Whilst the theoretical benefits of GLP-1 receptor agonists in inflammatory conditions are being explored in research settings, patients considering this approach must understand both the potential advantages and significant risks associated with off-label use
Physicians can tailor these injections to meet individual patients specific health conditions, needs, and objectives
If side effects persist despite adjustments, reducing the dose or discontinuing treatment may be necessary
In day-surgery patients, KET improved dischargeability and satisfaction
Vascular pathologies in chronic kidney disease: pathophysiological mechanisms and novel therapeutic approaches
Under basal conditions, Nrf2 is degraded through kelch-like erythroid cell-derived protein with CNC homology-associated protein 1 (Keap1)-dependent ubiquitination and proteasomal degradation